
Pharmacokinetics and target attainment of fluoroquinolones in older adults : a systematic review
- Author
- Cristina De Petter, Stef De Ryck, Arnaud De Clercq (UGent) , Jeroen Vervalcke (UGent) , Pieter De Cock (UGent) , Mirko Petrovic (UGent) , Tania Desmet (UGent) and Peter De Paepe (UGent)
- Organization
- Abstract
- With the expanding population of older adults and their unique care profile, there is an urgent need for better clarity on fluoroquinolone pharmacokinetics (PK) and dosing. Older adults are often excluded from clinical trials. This study aims to bridge that gap by summarizing existing literature on fluoroquinolone PK in older adults and exploring potential covariates that influence PK and target attainment. This is a systematic review using four online databases. The articles were screened in Rayyan and EndNote and a table was made for data extraction. In this review, 44 articles were included, covering nine fluoroquinolones. These studies examined oral and intravenous routes. Comparisons with younger control groups often indicated a higher AUC, Cmax, T½ and lower CL and Vd in older adults. Renal function was observed to be a covariate of CL in 18.8% of the articles. 72.7% reported dosing recommendations. Target attainment was addressed in 29.5% of studies. This review highlighted the limited research on the PK and target attainment in older adults. Small sample sizes, lack of comparator groups, and insufficient focus on older subpopulations and renal function impact the reliability of these findings. Renal function seemed critical for evidence-based dosing. There is an urgent need for more research on fluoroquinolone PK, such as popPK studies and Monte Carlo-simulations, to provide dosing recommendations.
- Keywords
- Pharmacokinetics, antibiotics
Citation
Please use this url to cite or link to this publication: http://hdl.handle.net/1854/LU-01JQ65K6HK1WKM0Q9423K36NHD
- MLA
- De Petter, Cristina, et al. “Pharmacokinetics and Target Attainment of Fluoroquinolones in Older Adults : A Systematic Review.” Research Day 2025, Abstracts, Ghent University, 2025.
- APA
- De Petter, C., De Ryck, S., De Clercq, A., Vervalcke, J., De Cock, P., Petrovic, M., … De Paepe, P. (2025). Pharmacokinetics and target attainment of fluoroquinolones in older adults : a systematic review. Research Day 2025, Abstracts. Presented at the Research Day 2025, Merelbeke, Belgium.
- Chicago author-date
- De Petter, Cristina, Stef De Ryck, Arnaud De Clercq, Jeroen Vervalcke, Pieter De Cock, Mirko Petrovic, Tania Desmet, and Peter De Paepe. 2025. “Pharmacokinetics and Target Attainment of Fluoroquinolones in Older Adults : A Systematic Review.” In Research Day 2025, Abstracts. Ghent University.
- Chicago author-date (all authors)
- De Petter, Cristina, Stef De Ryck, Arnaud De Clercq, Jeroen Vervalcke, Pieter De Cock, Mirko Petrovic, Tania Desmet, and Peter De Paepe. 2025. “Pharmacokinetics and Target Attainment of Fluoroquinolones in Older Adults : A Systematic Review.” In Research Day 2025, Abstracts. Ghent University.
- Vancouver
- 1.De Petter C, De Ryck S, De Clercq A, Vervalcke J, De Cock P, Petrovic M, et al. Pharmacokinetics and target attainment of fluoroquinolones in older adults : a systematic review. In: Research Day 2025, Abstracts. Ghent University; 2025.
- IEEE
- [1]C. De Petter et al., “Pharmacokinetics and target attainment of fluoroquinolones in older adults : a systematic review,” in Research Day 2025, Abstracts, Merelbeke, Belgium, 2025.
@inproceedings{01JQ65K6HK1WKM0Q9423K36NHD, abstract = {{With the expanding population of older adults and their unique care profile, there is an urgent need for better clarity on fluoroquinolone pharmacokinetics (PK) and dosing. Older adults are often excluded from clinical trials. This study aims to bridge that gap by summarizing existing literature on fluoroquinolone PK in older adults and exploring potential covariates that influence PK and target attainment. This is a systematic review using four online databases. The articles were screened in Rayyan and EndNote and a table was made for data extraction. In this review, 44 articles were included, covering nine fluoroquinolones. These studies examined oral and intravenous routes. Comparisons with younger control groups often indicated a higher AUC, Cmax, T½ and lower CL and Vd in older adults. Renal function was observed to be a covariate of CL in 18.8% of the articles. 72.7% reported dosing recommendations. Target attainment was addressed in 29.5% of studies. This review highlighted the limited research on the PK and target attainment in older adults. Small sample sizes, lack of comparator groups, and insufficient focus on older subpopulations and renal function impact the reliability of these findings. Renal function seemed critical for evidence-based dosing. There is an urgent need for more research on fluoroquinolone PK, such as popPK studies and Monte Carlo-simulations, to provide dosing recommendations.}}, author = {{De Petter, Cristina and De Ryck, Stef and De Clercq, Arnaud and Vervalcke, Jeroen and De Cock, Pieter and Petrovic, Mirko and Desmet, Tania and De Paepe, Peter}}, booktitle = {{Research Day 2025, Abstracts}}, keywords = {{Pharmacokinetics,antibiotics}}, language = {{eng}}, location = {{Merelbeke, Belgium}}, pages = {{1}}, publisher = {{Ghent University}}, title = {{Pharmacokinetics and target attainment of fluoroquinolones in older adults : a systematic review}}, url = {{https://www.ugent.be/ge/en/research/research-day}}, year = {{2025}}, }